EverGlade Insights Archives - Page 7 of 9 - EverGlade

EverGlade Insights

NIH resume issuing grants

NIH Admits Funding Freeze Was Illegal, Resumes Issuing Grants

Leave a Comment / All Posts, Life Sciences, NIH / By

Overview In a major development for the biomedical research community, the National Institutes of Health (NIH) has officially acknowledged that its recent funding freeze was unlawful and has announced the resumption of grant distributions. This decision follows weeks of controversy and legal challenges, during which research institutions, universities, and lawmakers criticized the abrupt halt in […]

NIH Admits Funding Freeze Was Illegal, Resumes Issuing Grants Read More »

ARPA-H_RAPID rare disease diagnostics

RAPID Solicitation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of

RAPID Solicitation Read More »

Court Blocks NIH Cap Indirect Cost Rate

Court Blocks NIH Cap on Indirect Cost Rates

Leave a Comment / All Posts, Life Sciences, NIH / By

Court Blocks NIH Cap on Indirect Cost Rates for Government Contracts In a significant development for research institutions and federal contractors, a federal judge has temporarily blocked the National Institutes of Health (NIH) from enforcing its cap on indirect cost rates. This decision comes as a result of a temporary restraining order (TRO) issued by

Court Blocks NIH Cap on Indirect Cost Rates Read More »

Safe Lithium-Ion Battery Development DOE

Safe Lithium-Ion Battery Development

Leave a Comment / All Posts, DOE, Emerging Technologies / By

Lithium Ion Battery Development Overview of the Solicitation The Department of Energy (DOE) and affiliates have released a Request for Proposals (RFP) for the development of a safe lithium-ion battery. This initiative aims to create a backup energy storage system capable of providing 2.4 MW*hrs of usable energy while ensuring a robust safety posture. The

Safe Lithium-Ion Battery Development Read More »

NIH Supplemental Guidance

Understanding the NIH Supplemental Guidance on Indirect Cost Rates

Leave a Comment / All Posts, Life Sciences, NIH / By

Overview The National Institutes of Health (NIH) has issued Supplemental Guidance to the 2024 NIH Grants Policy Statement regarding Indirect Cost Rates (NOT-OD-25-068). This update introduces a standardized 15% indirect cost rate for all applicable grants, aiming to streamline financial policies and enhance funding efficiency for research institutions. Purpose of the Guidance The primary objective

Understanding the NIH Supplemental Guidance on Indirect Cost Rates Read More »

molecular science DARPA

Unlocking the Future of Microsystems: DARPA’s MICA Program

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

DARPA, Microsystems Induced CAtalysis (MICA) Program Overview of the MICA Program The Defense Advanced Research Projects Agency (DARPA) has recently announced a groundbreaking funding opportunity, titled “Microsystems Induced CAtalysis” (MICA). This Broad Agency Announcement (BAA) aims to enhance molecular science by creating advanced tools and techniques for controlling molecular catalysts using microsystems. This initiative goes

Unlocking the Future of Microsystems: DARPA’s MICA Program Read More »

antiviral therapeutics against filoviruses

New Opportunities with DRIVe: ReBooT and RePAIR Amendments

Leave a Comment / All Posts, BARDA, Life Sciences / By

Amendment 034 – DRIVe EZ BAA_ReBooT_RePAIR New Opportunities with DRIVe: ReBooT and RePAIR Amendments The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation & Ventures (DRIVe) has announced updates to its Easy Broad Agency Announcement (EZ-BAA) with Amendment #034. This amendment reopens and revises the ReBooT (AOI #22) program and pauses the

New Opportunities with DRIVe: ReBooT and RePAIR Amendments Read More »

EverGlade

Unlocking Federal Opportunities for AI & Technology Innovators

Leave a Comment / AI, All Posts, Emerging Technologies / By

Securing federal funding is more than a financial boost – it’s a strategic move that positions your company as a leader in innovation. EverGlade’s proven process helps small and medium-sized AI and tech firms navigate complex federal funding landscapes. Our process works because we focus on your business goals, not just technical details, ensuring maximum

Unlocking Federal Opportunities for AI & Technology Innovators Read More »

Leveraging AI to Enhance Business Intelligence

Leveraging AI to Enhance Business Intelligence

Leave a Comment / All Posts, DIU, Emerging Technologies / By

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H PROSPR prolonging resilience

EverGlade Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H-SOL-25-125_Special_Notice ARPA-H’s PROSPR Program The Advanced Research Projects Agency for Health (ARPA-H) has announced the PROactive Solutions for Prolonging Resilience (PROSPR) initiative, an ambitious program designed to extend the healthspan of Americans by addressing the underlying causes of age-related health loss. By pioneering innovative interventions that target age-induced health deterioration, ARPA-H aims to revolutionize healthcare

EverGlade Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR) Read More »

PAHPA program funding

After the CR: Funding Opportunities and Gaps in Pandemic Preparedness

Leave a Comment / All Posts, BARDA, Life Sciences / By

Congress’s passage of a continuing resolution (CR) has averted a shutdown and provided temporary relief until late March. However, this short-term fix exposes significant gaps in public health and technology preparedness that demand immediate attention. As critical programs approach expiration and threats beyond the Pandemic and All-Hazards Preparedness Act (PAHPA) remain unresolved, lawmakers have a

After the CR: Funding Opportunities and Gaps in Pandemic Preparedness Read More »

Radiation & Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices

Leave a Comment / All Posts, Life Sciences, NIAID / By

NIAID_Presolicitation_Notice_Rad_Nuc MCMs Overview of Solicitation The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices. This Broad Agency Announcement (BAA 75N93024R00020) is an invitation for innovators in the critical field of radiation emergency

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices Read More »

Scroll to Top